Suresh Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Suresh Kumar has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Manoj Kashyap
Department of Pharmacognosy, School of Pharmacy, Pragjyotishpur University, Hajongbari, Chandrapur, Guwahati, Assam, 781150, India
2 shared publications - Nisha Chandila
Department of Pharmacology, Jamia Hamdard, Hamdard Nagar, New Delhi, 110062, India
2 shared publications - Durgaprasad Kemisetti
Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, 781026, India
1 shared publication - Hiyashree Sharmah
School of Pharmacy, Pragjyotishpur University, Chandrapur, Guwahati, Kamrup (M), India
1 shared publication - Kumara Swamy Samanthula
Department of Pharmaceutical Science, Assam Down Town University (AdtU)
1 shared publication - Lokman Ali Ahmed
NEF College of Pharmacy, Guwahati, Kamrup, India
1 shared publication
Latest Publications
- 1 September 2026
- Published by Bentham Science Publishers Ltd. in The International Journal of Gastroenterology and Hepatology Diseases
- Vol. 05 (1) , 1-12
Evaluation of the Hepatoprotective Efficacy of Mimusops elengi L. Fruits in a Carbon Tetrachloride-induced Rat Model
Introduction: Liver diseases are a major global health burden, and oxidative stress plays a key role in the development of hepatocellular injury. Mimusops elengi L. fruits contain bioactive phytochemicals with reported antioxidant properties. This study aimed to evaluate the hepatoprotective activity of aqueous Mimusops elengi fruit extract against carbon tetrachloride (CCl4)-induced liver injury in Wistar rats. Methods: Male Wistar rats were randomly allocated into five groups (n = 5). Hepatic injury was induced using CCl4 (1 mL/kg, i.p.) for 15 days. Animals received Mimusops elengi fruit extract (200 and 400 mg/kg, orally) or silymarin (25 mg/kg). Serum ALT, AST, and catalase activity were evaluated, followed by histopathological examination of liver tissues. Results: CCl4 administration significantly increased serum ALT and AST levels while reducing catalase activity, indicating severe hepatic injury. Treatment with Mimusops elengi fruit extract significantly reduced liver enzyme levels and improved antioxidant status in a dose-dependent manner. Histopathological examination demonstrated preservation of hepatic architecture, reduced necrosis and decreased inflammatory changes, particularly at 400 mg/kg. Discussion: The hepatopr tective activity observed may be attributed to the antioxidant and membrane- stabilizing properties of flavonoids, tannins, and saponins present in Mimusops elengi fruits. The biochemical and histopathological findings collectively support the traditional medicinal use of this plant for liver protection and suggest its potential as a natural hepatoprotective agent. Conclusion: Mimusops elengi fruit extract exhibits significant hepatoprotective effects against CCl4-induced liver injury, likely mediated through antioxidant mechanisms. These findings support its potential as a natural therapeutic agent, although further studies are required to elucidate its active constituents and molecular pathways.
- 1 September 2026
- Published by Bentham Science Publishers Ltd. in The International Journal of Gastroenterology and Hepatology Diseases
- Vol. 05 (1) , 1-12
Evaluation of the Hepatoprotective Efficacy of Mimusops elengi L. Fruits in a Carbon Tetrachloride-induced Rat Model
Introduction: Liver diseases are a major global health burden, and oxidative stress plays a key role in the development of hepatocellular injury. Mimusops elengi L. fruits contain bioactive phytochemicals with reported antioxidant properties. This study aimed to evaluate the hepatoprotective activity of aqueous Mimusops elengi fruit extract against carbon tetrachloride (CCl4)-induced liver injury in Wistar rats. Methods: Male Wistar rats were randomly allocated into five groups (n = 5). Hepatic injury was induced using CCl4 (1 mL/kg, i.p.) for 15 days. Animals received Mimusops elengi fruit extract (200 and 400 mg/kg, orally) or silymarin (25 mg/kg). Serum ALT, AST, and catalase activity were evaluated, followed by histopathological examination of liver tissues. Results: CCl4 administration significantly increased serum ALT and AST levels while reducing catalase activity, indicating severe hepatic injury. Treatment with Mimusops elengi fruit extract significantly reduced liver enzyme levels and improved antioxidant status in a dose-dependent manner. Histopathological examination demonstrated preservation of hepatic architecture, reduced necrosis and decreased inflammatory changes, particularly at 400 mg/kg. Discussion: The hepatopr tective activity observed may be attributed to the antioxidant and membrane- stabilizing properties of flavonoids, tannins, and saponins present in Mimusops elengi fruits. The biochemical and histopathological findings collectively support the traditional medicinal use of this plant for liver protection and suggest its potential as a natural hepatoprotective agent. Conclusion: Mimusops elengi fruit extract exhibits significant hepatoprotective effects against CCl4-induced liver injury, likely mediated through antioxidant mechanisms. These findings support its potential as a natural therapeutic agent, although further studies are required to elucidate its active constituents and molecular pathways.
- 4 March 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (4) , 5053-5066
Current advances in 7-hydroxycoumarin derivatives as potential therapeutic agents for Alzheimer’s disease
Alzheimer’s disease (AD), a multifactorial neurodegenerative disorder, remains a major cause of cognitive decline in the aging population. Current pharmacological interventions provide only symptomatic relief, highlighting the urgent need for novel therapeutic strategies capable of modifying disease progression. Coumarins, particularly 7-hydroxycoumarin and its synthetic derivatives, have attracted considerable interest due to their broad pharmacological potential, including cholinesterase inhibition, monoamine oxidase (MAO) inhibition, antioxidant, anti-amyloidogenic and metal-chelating activities. This review presents a comprehensive analysis of synthetic 7-hydroxycoumarin derivatives reported over the past 15 years as potential anti-Alzheimer agents, classifying them according to their actions on key pathological hallmarks of AD, such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), MAO-B, β-amyloid (Aβ) aggregation, oxidative stress and neuroinflammation. Structure–activity relationship (SAR) analysis reveals that substitutions at the 7-, 3- and 4-positions of the coumarin scaffold critically influence pharmacological potency and selectivity, with aromatic and alkyl amine substitutions generally enhancing enzyme inhibition and neuroprotective effects. Several derivatives exhibited sub-micromolar to nanomolar inhibitory activity against AChE and MAO-B, along with antioxidant and anti-Aβ aggregation properties, supporting their multifunctional behaviour. Overall, this review highlights the therapeutic promise of 7-hydroxycoumarin derivatives as multitarget-directed ligands (MTDLs) and provides valuable insights for the rational design of new lead compounds for Alzheimer’s disease. Graphical abstract
- 4 March 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (4) , 5053-5066
Current advances in 7-hydroxycoumarin derivatives as potential therapeutic agents for Alzheimer’s disease
Alzheimer’s disease (AD), a multifactorial neurodegenerative disorder, remains a major cause of cognitive decline in the aging population. Current pharmacological interventions provide only symptomatic relief, highlighting the urgent need for novel therapeutic strategies capable of modifying disease progression. Coumarins, particularly 7-hydroxycoumarin and its synthetic derivatives, have attracted considerable interest due to their broad pharmacological potential, including cholinesterase inhibition, monoamine oxidase (MAO) inhibition, antioxidant, anti-amyloidogenic and metal-chelating activities. This review presents a comprehensive analysis of synthetic 7-hydroxycoumarin derivatives reported over the past 15 years as potential anti-Alzheimer agents, classifying them according to their actions on key pathological hallmarks of AD, such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), MAO-B, β-amyloid (Aβ) aggregation, oxidative stress and neuroinflammation. Structure–activity relationship (SAR) analysis reveals that substitutions at the 7-, 3- and 4-positions of the coumarin scaffold critically influence pharmacological potency and selectivity, with aromatic and alkyl amine substitutions generally enhancing enzyme inhibition and neuroprotective effects. Several derivatives exhibited sub-micromolar to nanomolar inhibitory activity against AChE and MAO-B, along with antioxidant and anti-Aβ aggregation properties, supporting their multifunctional behaviour. Overall, this review highlights the therapeutic promise of 7-hydroxycoumarin derivatives as multitarget-directed ligands (MTDLs) and provides valuable insights for the rational design of new lead compounds for Alzheimer’s disease. Graphical abstract
- 1 March 2026
- Published by Bentham Science Publishers Ltd. in Current Functional Foods
- Vol. 4 (2) , 1-15
Integrative Approaches to Depression: A Comparative Review of Allopathic and Phytochemical Therapies and their Challenges
Depression, affecting over 322 million people globally (WHO), remains a significant mental health challenge. While conventional treatments like synthetic antidepressants are effective, they often entail side effects, economic barriers, and limited accessibility, particularly in lowresource regions. This review highlights the potential of medicinal plants and phytochemicals as alternative treatments for depression. Plants such as ginseng, Hypericum perforatum, ginger, and saffron exhibit antidepressant properties due to bioactive compounds like flavonoids, alkaloids, and saponins. Phytochemicals, including naringenin, quercetin, piperine, and berberine, enhance serotonin and brain-derived neurotrophic factor levels, promoting mood stabilization and cognitive support. These natural therapies offer an affordable, lower-risk option, particularly for individuals who cannot tolerate or afford synthetic drugs. However, efficacy and safety assessments are crucial, as some herbal treatments carry toxicity risks. Standardized quality checks and personalized approaches are essential to ensure optimal outcomes. By integrating medicinal plants into mental health care, particularly in low- and middle-income regions, we can provide accessible, safer alternatives to conventional antidepressants.
- 1 March 2026
- Published by Bentham Science Publishers Ltd. in Current Functional Foods
- Vol. 4 (2) , 1-15
Integrative Approaches to Depression: A Comparative Review of Allopathic and Phytochemical Therapies and their Challenges
Depression, affecting over 322 million people globally (WHO), remains a significant mental health challenge. While conventional treatments like synthetic antidepressants are effective, they often entail side effects, economic barriers, and limited accessibility, particularly in lowresource regions. This review highlights the potential of medicinal plants and phytochemicals as alternative treatments for depression. Plants such as ginseng, Hypericum perforatum, ginger, and saffron exhibit antidepressant properties due to bioactive compounds like flavonoids, alkaloids, and saponins. Phytochemicals, including naringenin, quercetin, piperine, and berberine, enhance serotonin and brain-derived neurotrophic factor levels, promoting mood stabilization and cognitive support. These natural therapies offer an affordable, lower-risk option, particularly for individuals who cannot tolerate or afford synthetic drugs. However, efficacy and safety assessments are crucial, as some herbal treatments carry toxicity risks. Standardized quality checks and personalized approaches are essential to ensure optimal outcomes. By integrating medicinal plants into mental health care, particularly in low- and middle-income regions, we can provide accessible, safer alternatives to conventional antidepressants.